See also this year's filing and all EDGAR filings for this company.
PDF Report 0000847464_2017_SPRING_PHARMACEUTICAL_GROUP_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000847464')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000847464, SPRING PHARMACEUTICAL GROUP INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 12,295,147 |
| 2 | PropertyPlantAndEquipmentNet | 12,872,997 |
| 3 | remainder_Assets | 56,147,363 |
| 4 | LiabilitiesCurrent | 965,956 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 36,600,154 |
| 11 | remainder_Revenues | 47,827,108 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -6,724,968 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 81,315,507 |
| 1 | Liabilities | 965,956 |
| 2 | Expenses | 36,600,154 |
| 3 | Revenues | 47,827,108 |
| 4 | StockholdersEquity | 80,349,551 |
| 5 | NetIncome | 11,226,954 |
| 6 | ComprehensiveNetIncome | 7,864,470 |
| 7 | BaseVar | 86,716,846 |
| 8 | EconomicCapitalRatio | 3.55 |
Edgar->Model Mapping
Feature Distribution
